Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
45 /100
MEDIUM RISK
Score updated Oct 13, 2026

URGN — UroGen Pharma Ltd. Dilution Risk Tracker

Track URGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track URGN — Get alerts when the score changes →

As of October 13, 2026, UroGen Pharma Ltd. (URGN) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. UroGen Pharma Ltd. has a market capitalization of $1.87B, 48.88M shares outstanding, 174 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔔 Track URGN — Get forecast alerts →

Market Data

Market Cap$1.87B
Shares Outstanding48.88M
Float43.18M
Cash$109.30M
Debt$188.73M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore45/100DilutionWatch score record
Shares Outstanding48.88MVerified float table or market cache
Public Float43.18MVerified float table or market cache
Market Cap$1.87BMarket data cache
Cash Runway9.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 14.4% shares (2026Q1 vs prior)
174 institutional holders · 53.57M shares
#1 MORGAN STANLEY 7.65M shares
#2 RTW INVESTMENTS, LP 4.54M shares
#3 BlackRock, Inc. 2.85M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.77M
Days to Cover9.9
% of Float18.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-02
xbrl XBRL CONVERTIBLE 2026-03-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual URGN Dilution Snapshot

UroGen Pharma Ltd. (URGN) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

URGN's DilutionScore is currently 45/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 38/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202645/100MEDIUM53 days
Jul 16 – Aug 21, 202638/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

URGN shares outstanding have increased 4.1% from 46.81M (Mar 2026) to 48.72M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202648.72M43.18M▲ 11.56%
May 15, 202648.72M38.71M▲ 0.03%
May 08, 202648.72M38.70M▲ 0.08%
Apr 26, 202648.68M38.66M▲ 0.01%
Mar 05, 202646.81M38.66M▲ 1.05%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track URGN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment URGN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking URGN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for URGN
URGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.